2 Marijuana Stocks Short-Sellers Are Betting Against -- and Why They Could Be Flat-Out WrongThe Motley Fool • 01/26/20
FDA-backed CBD drug brings in $296 million in 'incredible launch year,' GW Pharma CEO saysCNBC • 01/17/20
GW Pharmaceuticals' Preliminary Q4 Revenue of $108 Million Beats ExpectationsThe Motley Fool • 01/14/20
GW Pharmaceuticals Pre-Announces Preliminary Unaudited Fourth Quarter and Full-Year 2019 Net Product SalesGlobeNewsWire • 01/12/20
'Exceeded Our Expectations': First Latin American Study On CBD, Epilepsy CompletedBenzinga • 12/07/19